Results 171 to 180 of about 3,909 (222)

Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Olayinka OT, Orelus J, Nisar MR, Kotha R, Saad-Omer SI, Singh S, Yu AK.   +6 more
europepmc   +1 more source

Efficacy and Safety of Terlipressin Infusion in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): A Retrospective Observational Study. [PDF]

Cureus
Gowda M, Dilipbhai DM, Jalihal U, Kumar MP, Gowda S B, Jain A, Ganjoo N.   +6 more
europepmc   +1 more source

Non-mechanical haemodynamic support in acute pulmonary thromboembolism: a scoping review. [PDF]

Intensive Care Med Exp
Body W, Steckle S, Haggerty A, Putt M, Coyer F, Milford EM.   +5 more
europepmc   +1 more source

Severe Hyponatremia Associated With Terlipressin Use in Esophageal Variceal Bleeding. [PDF]

Cureus
AlKindi F, AlHaj O, Alhanaee A, Almazrouei R, Boobes Y.   +4 more
europepmc   +1 more source

EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications. [PDF]

JHEP Rep
Rautou PE, Lisman T, Hernandez-Gea V, Ripoll C.   +3 more
europepmc   +1 more source

Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO. [PDF]

Kidney360
Belcher JM.
europepmc   +1 more source

Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON. [PDF]

Kidney360
Willows J, Hiremath S.
europepmc   +1 more source

Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population. [PDF]

Liver Transpl
Reddy KR, Weinberg EM, Gonzalez SA, Izzy MJ, Simonetto DA, Frederick RT, Rubin RA, Fricker Z, Ikahihifo-Bender J, Harte M, Garcia S, Campbell K, Olofson A, Razavi RF, James JM, Patel H, Kim-Lee G, Witkiewicz S, Tobin W, Jamil K.   +19 more
europepmc   +1 more source

Corrigendum to "Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure". [PDF]

Aliment Pharmacol Ther
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combination of terlipressin and noradrenaline versus terlipressin in hepatorenal syndrome with early non-response to terlipressin infusion:  A randomized trial

Indian Journal of Gastroenterology, 2023
Terlipressin and noradrenaline are effective in the management of hepatorenal syndrome (HRS). There are no reports on the combination of these vasoconstrictors in type-1 HRS.To evaluate terlipressin with or without noradrenaline in type-1 HRS not responding to terlipressin at 48 hours.Sixty patients were randomized to receive either terlipressin (group
Virendra Singh, Akshaya Jayachandran, Arka De, Akash Singh, Shivani Chandel, Navneet Sharma   +5 more
openaire   +2 more sources